Cargando…
Mutation of Respiratory Syncytial Virus G Protein’s CX3C Motif Attenuates Infection in Cotton Rats and Primary Human Airway Epithelial Cells
Despite being a high priority for vaccine development, no vaccine is yet available for respiratory syncytial virus (RSV). A live virus vaccine is the primary type of vaccine being developed for young children. In this report, we describe our studies of infected cotton rats and primary human airway e...
Autores principales: | Ha, Binh, Chirkova, Tatiana, Boukhvalova, Marina S., Sun, He Ying, Walsh, Edward E., Anderson, Christopher S., Mariani, Thomas J., Anderson, Larry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789749/ https://www.ncbi.nlm.nih.gov/pubmed/31330970 http://dx.doi.org/10.3390/vaccines7030069 |
Ejemplares similares
-
Metabolic Reprogramming of Nasal Airway Epithelial Cells Following Infant Respiratory Syncytial Virus Infection
por: Connelly, Andrew R., et al.
Publicado: (2021) -
Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus
por: Boukhvalova, MS, et al.
Publicado: (2018) -
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
por: Johnson, Sara M., et al.
Publicado: (2015) -
Evolution of protection after maternal immunization for respiratory syncytial virus in cotton rats
por: Blanco, Jorge C. G., et al.
Publicado: (2021) -
Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease
por: Jorquera, Patricia A., et al.
Publicado: (2013)